Piperidino-hydrocarbon compounds as novel non-imidazole histamine H(3)-receptor antagonists.

[1]  K. Buchheit,et al.  Study of the contractile effect of 5-hydroxytryptamine (5-HT) in the isolated longitudinal muscle strip from guinea-pig ileum , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  J. Schwartz,et al.  Influence of imidazole replacement in different structural classes of histamine H(3)-receptor antagonists. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  J. Boutin,et al.  Genomic organization and characterization of splice variants of the human histamine H3 receptor. , 2001, The Biochemical journal.

[4]  R. Leurs,et al.  Identification of rat H3 receptor isoforms with different brain expression and signaling properties. , 2001, Molecular pharmacology.

[5]  Holger Stark,et al.  High constitutive activity of native H3 receptors regulates histamine neurons in brain , 2000, Nature.

[6]  J. Schwartz,et al.  Novel histamine H(3)-receptor antagonists with carbonyl-substituted 4-(3-(phenoxy)propyl)-1H-imidazole structures like ciproxifan and related compounds. , 2000, Journal of medicinal chemistry.

[7]  O. Zuiderveld,et al.  Non‐Imidazole Histamine H3 Ligands, Part 2: New 2‐Substituted Benzothiazoles as Histamine H3 Antagonists , 1999, Archiv der Pharmazie.

[8]  O. Zuiderveld,et al.  Non-imidazole histamine H3 ligands. Part I. Synthesis of 2-(1-piperazinyl)- and 2-(hexahydro-1H-1,4-diazepin-1-yl)benzothiazole derivatives as H3-antagonists with H1 blocking activities. , 1999, Farmaco.

[9]  J. Schwartz,et al.  Novel partial agonists for the histamine H(3) receptor with high in vitro and in vivo activity. , 1999, Journal of medicinal chemistry.

[10]  M. Jackson,et al.  Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.

[11]  S. L. Yates,et al.  Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex. , 1999, Biochemical pharmacology.

[12]  J. Schwartz,et al.  Synthesis of Potent Non‐imidazole Histamine H3‐Receptor Antagonists , 1998, Archiv der Pharmazie.

[13]  J. Schwartz,et al.  Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. , 1998, The Journal of pharmacology and experimental therapeutics.

[14]  J. Schwartz,et al.  General construction pattern of histamine H3-receptor antagonists: change of a paradigm. , 1998, Bioorganic & medicinal chemistry letters.

[15]  S. L. Yates,et al.  High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models. , 1998, European journal of pharmacology.

[16]  H. Stark,et al.  Improvement by FUB 181, a novel histamine H3-receptor antagonist, of learning and memory in the elevated plus-maze test in mice , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[17]  S. L. Yates,et al.  New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine. , 1998, Bioorganic & medicinal chemistry letters.

[18]  R. Leurs,et al.  Therapeutic potential of histamine H3 receptor agonists and antagonists. , 1998, Trends in pharmacological sciences.

[19]  H. Haas,et al.  International Union of Pharmacology. XIII. Classification of histamine receptors. , 1997, Pharmacological reviews.

[20]  R. Leurs,et al.  Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats , 1996, British journal of pharmacology.

[21]  J. Schwartz,et al.  Inhibition of histamine versus acetylcholine metabolism as a mechanism of tacrine activity. , 1996, European journal of pharmacology.

[22]  J. C. Barnes,et al.  Novel 1, 2, 4-oxadiazoles as potent and selective histamine H3 receptor antagonists , 1996 .

[23]  H. Stark,et al.  DEVELOPMENTS OF HISTAMINE H3-RECEPTOR ANTAGONISTS , 1996 .

[24]  K. Onodera,et al.  Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice. , 1995, Life sciences.

[25]  H. Pertz,et al.  In‐vitro Pharmacology of Sarpogrelate and the Enantiomers of its Major Metabolite: 5‐HT2A Receptor Specificity, Stereoselectivity and Modulation of Ritanserin‐induced Depression of 5‐HT Contractions in Rat Tail Artery , 1995, The Journal of pharmacy and pharmacology.

[26]  H. Stark,et al.  Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models , 1994, British journal of pharmacology.

[27]  J. Schwartz,et al.  S-[2-(4-imidazolyl)ethyl]isothiourea, a highly specific and potent histamine H3 receptor agonist. , 1992, The Journal of pharmacology and experimental therapeutics.

[28]  J. Schwartz,et al.  Sensitive Radioimmunoassays for Histamine and tele‐Methylhistamine in the Brain , 1989, Journal of neurochemistry.

[29]  J. Schwartz,et al.  Effects of histamine H3-receptor ligands on various biochemical indices of histaminergic neuron activity in rat brain. , 1989, European journal of pharmacology.

[30]  J. Schwartz,et al.  Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors , 1987, Neuroscience.

[31]  J. Schwartz,et al.  Autoregulation of histamine release in brain by presynaptic H3-receptors , 1985, Neuroscience.

[32]  J. Schwartz,et al.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor , 1983, Nature.

[33]  H. Reich,et al.  Organoselenium chemistry. Formation of acetylenes and allenes by syn elimination of vinyl selenoxides , 1980 .

[34]  E. Corey,et al.  A synthetic method for formyl→ethynyl conversion (RCHO→RCCH or RCCR′) , 1972 .

[35]  R. B. Parker,et al.  Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation. I. Agonists. , 1971, The Journal of pharmacology and experimental therapeutics.

[36]  E. F. Magoon,et al.  Reductions of acetylenes and conjugated diolefins by lithium aluminum hydride , 1967 .

[37]  R. F. Harris,et al.  The Preparation of Lithium Acetylide-Ethylenediamine , 1963 .